#GynCSM Transcript

Healthcare social media transcript of the #GynCSM hashtag.
().
See #GynCSM Influencers/Analytics.

ProfileTweet
GYN Cancer | #GYNCSM @gyncsm
Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers.
Dee Sparacio @womenofteal
RT @gyncsm: Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers.
GYN Cancer | #GYNCSM @gyncsm
Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm
Christina Lizaso @btrfly12
Christina Lizaso – passionate re: community engagement and cancer care. I’ll be moderating as @gyncsm today. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm
Dee Sparacio @womenofteal
Dee here! Dx with #ovca Stage3B 2005, recurrence 2008, Ovarian Cancer research advocate, blogger, co-Author of “100 Questions and Answers about Ovarian cancer” & co-moderator #gyncsm
GYN Cancer | #GYNCSM @gyncsm
If you prefer to “listen only” during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here. Please continue intro's and welcomes - we'll start in w/ the "ground rules" :) and tips!
Dee Sparacio @womenofteal
RT @gyncsm: If you prefer to “listen only” during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here. Please continue intro's and welcomes - we'll start in w/ the "ground rules" :) and tips!
GYN Cancer | #GYNCSM @gyncsm
The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Dee Sparacio @womenofteal
RT @gyncsm: The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Suzie Siegel @SuzieSiegel
Survivor of metastatic vaginal #leiomyosarcoma. My head's still swimming from #ASCO22 online. #gyncsm
Dee Sparacio @womenofteal
#gyncsm tagged resources and referrals are not a substitute for speaking with your doctor who understands your individual needs and history.
GYN Cancer | #GYNCSM @gyncsm
#gyncsm is not a forum for individual medical advice. Resources and referrals and provided solely for information and convenience.
Dee Sparacio @womenofteal
@SuzieSiegel Hi Suzie - Yes there were lots of studies on sarcomas and other rare cancers. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Are you new to tweet chats? Follow hashtag #gyncsm under "Explore" and "Latest" and include it in every tweet during the next hour to engage with others about this topic. #gyncsm
Shannon Westin @ShannonWestin
RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Are you new to tweet chats? Follow hashtag #gyncsm under "Explore" and "Latest" and include it in every tweet during the next hour to engage with others about this topic. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Welcome to those joining and also those “listening in”. Be sure to tweet #gyncsm so we know you are here. You can always tweet, DM or email us with questions/comments after the chat is over. https://t.co/XYaP3OTgsG #gyncsm
Sarah Temkin @temkins
RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm
Dee Sparacio @womenofteal
Remember - Twitter is an open social network and posts are public. Use a Direct Message to exchange email addresses/personal information.#gyncsm
Shannon Westin @ShannonWestin
Hi all! Gyn onc from @MDAndersonNews - excited to be here for the chat! #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI
Sarah Temkin @temkins
RT @gyncsm: Are you new to tweet chats? Follow hashtag #gyncsm under "Explore" and "Latest" and include it in every tweet during the next hour to engage with others about this topic. #gyncsm
Sarah Temkin @temkins
RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI
Christina Lizaso @btrfly12
RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI
Dee Sparacio @womenofteal
Thank you to all who have tweeted valuable information to our community during the past month using #gyncsm along with the #ASCO22 hashtag this pas weekend. We appreciate those who helped promote tonight's chat.
GYN Cancer | #GYNCSM @gyncsm
We’ll use a topic format with T1:; T2: etc. Please include the corresponding T#: at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI
Dee Sparacio @womenofteal
RT @gyncsm: We’ll use a topic format with T1:; T2: etc. Please include the corresponding T#: We’ll use a topic format with T1:; T2: etc. Please include the corresponding T#: at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Here comes Topic1 (T1:)... #gyncsm
Gary L. Thompson @garyleethompson
Listening in to #gyncsm tonight… virtual hugs from Texas to y’all!! 🤗🤗
GYN Cancer | #GYNCSM @gyncsm
T1: What #SGOMtg presentations did you personally find of most interest? Anything practice-changing? #gyncsm
Dee Sparacio @womenofteal
@garyleethompson Great to have you joining us Gary! #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T1: T1: What #SGOMtg presentations did you personally find of most interest? Anything practice-changing? #gyncsm
Suzie Siegel @SuzieSiegel
T1. @SamBoseMD's study on RAD51 foci formation predicting DNA damage repair deficiency, and how PARP inhibitors may help more women with gyn #leiomyosarcoma. #gyncsm
Christina Lizaso @btrfly12
T1: I appreciated the study on older cervical cancer patients and how the current guidelines to stop screening after 65 are not working well in practice as there are conditions that need to be present to stop. #gyncsm https://t.co/4yR0wbSsXj
Sarah Temkin @temkins
RT @btrfly12: T1: T1: I appreciated the study on older cervical cancer patients and how the current guidelines to stop screening after 65 are not working well in practice as there are conditions that need to be present to stop. #gyncsm https://t.co/4yR0wbSsXj
Gary L. Thompson @garyleethompson
@womenofteal Thank you… for all the folks I saw IRL at #ASCO22 still crazy how many I didn’t!! Such a big event. #gyncsm
Christina Lizaso @btrfly12
T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino :
Dee Sparacio @womenofteal
T1: For me Emeline Aviki's ,presentation on “Overspending on Dose-Specific Packaging of Lenvatinib for Endometrial Cancer,” which led to @EisaiUS announcing that it will expand its dose exchange program to cover dose reductions. #gyncsm
Dee Sparacio @womenofteal
RT @SuzieSiegel: T1. @SamBoseMD's study on RAD51 foci formation predicting DNA damage repair deficiency, and how PARP inhibitors may help more women with gyn #leiomyosarcoma. #gyncsm
Christina Lizaso @btrfly12
RT @SuzieSiegel: T1. @SamBoseMD's study on RAD51 foci formation predicting DNA damage repair deficiency, and how PARP inhibitors may help more women with gyn #leiomyosarcoma. #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: T1: T1: I appreciated the study on older cervical cancer patients and how the current guidelines to stop screening after 65 are not working well in practice as there are conditions that need to be present to stop. #gyncsm https://t.co/4yR0wbSsXj
Sarah Temkin @temkins
RT @btrfly12: T1: T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino :
Matthew Katz, MD 🇺🇸 💜 @subatomicdoc
RT @btrfly12: T1: T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino :
Dee Sparacio @womenofteal
Yup that one was a good one. #gyncsm
Lisa Davis Budzinski @lisadbudzinski
RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI
Dee Sparacio @womenofteal
@EisaiUS https://t.co/ExUMQyeRNV #gyncsm
Tobey @BRCAinfo
Hi #gyncsm Sorry I’m late
Martina Murphy, MD @DrMMurphy
@gyncsm @womenofteal @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte Hi all! Joining a bit late, tonight. Martina Murphy - Med gyn onc at UF. #gyncsm
Christina Lizaso @btrfly12
T1: At #SGOmtg this year it was nice to see there is some progress being made in ovarian cancer. It was also nice to see the other gyn cancers, rare cancers and disparities well represented. #gyncsm
Dee Sparacio @womenofteal
@BRCAinfo Hi Tobey . No problem we just started. Glad you are here. #gyncsm
Dee Sparacio @womenofteal
@DrMMurphy @gyncsm @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte Hello!!!! Thanks for joining us. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
We're wrapping up on sharing studies from #SGOmtg that were of interest, but as you join you can chime in even as we move along to Topic2... #gyncsm
Emeline Aviki, MD, MBA @EmelineAvikiMD
RT @btrfly12: T1: T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino :
Dee Sparacio @womenofteal
RT @gyncsm: We're wrapping up on sharing studies from #SGOmtg that were of interest, but as you join you can chime in even as we move along to Topic2... #gyncsm
Martina Murphy, MD @DrMMurphy
@btrfly12 @fumikochino Yes!!! I loved this especially seeing as we often have to make dose changes with this medication. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T2: Which #ASCO22 studies do you think might be of most interest to patients? #gyncsm
Shannon Westin @ShannonWestin
T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm
Suzie Siegel @SuzieSiegel
T2. @NassifElise's presentation on the gut microbiome & response to #immunotherapy. Eat more fiber! (Unless you're prone to bowel obstructions) #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm
Emeline Aviki, MD, MBA @EmelineAvikiMD
RT @womenofteal: T1: T1: For me Emeline Aviki's ,presentation on “Overspending on Dose-Specific Packaging of Lenvatinib for Endometrial Cancer,” which led to @EisaiUS announcing that it will expand its dose exchange program to cover dose reductions. #gyncsm
Christina Lizaso @btrfly12
#gyncsm I'm really excited to see more research into this in general!
Martina Murphy, MD @DrMMurphy
RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm
Emeline Aviki, MD, MBA @EmelineAvikiMD
RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm
Shannon Westin @ShannonWestin
💯 - very exciting to see research immediately translate to practice - #gyncsm
Dee Sparacio @womenofteal
Yes, Listening to the rare cancer presentations like for Neuroendocrine gynecologic tumors was very interesting. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T2: T2: Which #ASCO22 studies do you think might be of most interest to patients? #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm
Dee Sparacio @womenofteal
RT @SuzieSiegel: T2. @NassifElise's presentation on the gut microbiome & response to #immunotherapy. Eat more fiber! (Unless you're prone to bowel obstructions) #gyncsm
Dee Sparacio @womenofteal
@SuzieSiegel @NassifElise After I recurred they told me I was not getting anywhere near the fiber I should be getting. #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: 💯 - very exciting to see research immediately translate to practice - #gyncsm
GYN Cancer | #GYNCSM @gyncsm
For those interesting in some of the "headlines" from #SGOmtg, here are some collected articles https://t.co/pbKLJA7wLu https://t.co/KOGztbk1Bx #gyncsm
Shannon Westin @ShannonWestin
RT @SuzieSiegel: T2. @NassifElise's presentation on the gut microbiome & response to #immunotherapy. Eat more fiber! (Unless you're prone to bowel obstructions) #gyncsm
Shannon Westin @ShannonWestin
RT @gyncsm: For those interesting in some of the "headlines" from #SGOmtg, here are some collected articles https://t.co/pbKLJA7wLu https://t.co/KOGztbk1Bx #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T3: What are some of the current "hot topics" in gynecologic cancer research? Are there things still up for debate that patients/survivors/advocates should be aware of? #gyncsm
Dee Sparacio @womenofteal
T2 study done in Japan : bevacizumab (Avastin) added to first-line chemotherapy led to statistically significant improvements in PFS and (OS) in patients with advanced ovarian clear cell carcinoma (OCCC). Important those those with clear cell #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: For those interesting in some of the "headlines" from #SGOmtg, here are some collected articles https://t.co/pbKLJA7wLu https://t.co/KOGztbk1Bx #gyncsm
Tobey @BRCAinfo
For me ~ anything that involves #immunotherapy or #targetedtherapy is something I want to know more about in #cancer treatment #gyncsm
Héphaïstos @hephaistos_ai
RT @BRCAinfo: For me ~ anything that involves #immunotherapy or #targetedtherapy is something I want to know more about in #cancer treatment #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T3: T3: What are some of the current "hot topics" in gynecologic cancer research? Are there things still up for debate that patients/survivors/advocates should be aware of? #gyncsm
Dee Sparacio @womenofteal
RT @BRCAinfo: For me ~ anything that involves #immunotherapy or #targetedtherapy is something I want to know more about in #cancer treatment #gyncsm
Christina Lizaso @btrfly12
T3: where do things stand with HIPEC? Seems like I see conflicting info #gyncsm
Suzie Siegel @SuzieSiegel
@btrfly12 For uterine #leiomyosarcoma, it is still being studied. #gyncsm
Christina Lizaso @btrfly12
ASCO is huge but there seemed to be a pretty good amount of gynecologic cancer research. You can search through the abstracts at https://t.co/3znkNIiU7J #gyncsm
Shannon Westin @ShannonWestin
RT @btrfly12: ASCO is huge but there seemed to be a pretty good amount of gynecologic cancer research. You can search through the abstracts at https://t.co/3znkNIiU7J #gyncsm
Shannon Westin @ShannonWestin
RT @womenofteal: T2 study done in Japan : T2 study done in Japan : bevacizumab (Avastin) added to first-line chemotherapy led to statistically significant improvements in PFS and (OS) in patients with advanced ovarian clear cell carcinoma (OCCC). Important those those with clear cell #gyncsm
Christina Lizaso @btrfly12
T3: There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue. #gyncsm
Martina Murphy, MD @DrMMurphy
T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm
Shannon Westin @ShannonWestin
T3: Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: ASCO is huge but there seemed to be a pretty good amount of gynecologic cancer research. You can search through the abstracts at https://t.co/3znkNIiU7J #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: T3: T3: There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue. #gyncsm
Martina Murphy, MD @DrMMurphy
RT @btrfly12: T3: T3: There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue. #gyncsm
Christina Lizaso @btrfly12
T2: You can search for tweets with both #ASCO22 and #gyncsm to get a glimpse of some of the items covered.
Suzie Siegel @SuzieSiegel
@btrfly12 But anyone looking for gyn #sarcoma should be sure to look at the sarcoma tracks and posters. #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: T3: T3: Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! #gyncsm
Christina Lizaso @btrfly12
RT @DrMMurphy: T3 : T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm
Christina Lizaso @btrfly12
RT @SuzieSiegel: @btrfly12 But anyone looking for gyn #sarcoma should be sure to look at the sarcoma tracks and posters. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T4: What research on palliative care, exercise, nutrition, survivorship do you think will impact patients lives the most - or that survivors should ask their providers about? #gyncsm
Gary L. Thompson @garyleethompson
#gyncsm friends. #Thisismywhy I stayed in Evanston for #ASCO22 I went to school there, married #theloveofmylife, there. 1st home. Maureen was always Maureen, no matter what the cancer on the inside was called. I see each of you like I saw her. People first, not cancer first. ❤️
Christina Lizaso @btrfly12
@garyleethompson Thanks for all your advocacy and love poured out in her honor #gyncsm
Dee Sparacio @womenofteal
@btrfly12 It could benefit a subset of patients . Indian HIPEC study of EOC patients, surgery plus HIPEC offers potential benefits in PFS and OS rates, with acceptable rates of morbidity and mortality Ab 5525 #gyncsm
Suzie Siegel @SuzieSiegel
T4 & T5. Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! #gyncsm
Dee Sparacio @womenofteal
RT @DrMMurphy: T3 : T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm
Martina Murphy, MD @DrMMurphy
T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: T3: T3: Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! #gyncsm
Suzie Siegel @SuzieSiegel
RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm
Christina Lizaso @btrfly12
T4: I saw a study on better genetic education for ovarian cancer patients, but I don't remember a lot of quality of life studies in general. It was nice to see emphasis on financial toxicity though. #gyncsm
Christina Lizaso @btrfly12
RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm
Tobey @BRCAinfo
@garyleethompson Gary~ your love ❤️ shines through with every post. Truly sorry for your loss 🙏 Maureen must have been one very special lady. #gyncsm
Jorge Hoegl. MD @oncohoegl
RT @JournalCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Opportunities for precision oncology in a changing landscape https://t.co/jSpLcDxafe #gyncsm #gyncancer CC: @OncoAlert https://t.co/fxNkYeitij
Dee Sparacio @womenofteal
@ShannonWestin A few gyn studies are breaking down the reporting of results based on BRCA and HRD status #gyncsm
Martina Murphy, MD @DrMMurphy
@garyleethompson I love this - thank you for this reminder. People first, always ❤️🙏🏼❤️ #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: T2: T2: You can search for tweets with both #ASCO22 and #gyncsm to get a glimpse of some of the items covered.
Dee Sparacio @womenofteal
RT @SuzieSiegel: @btrfly12 But anyone looking for gyn #sarcoma should be sure to look at the sarcoma tracks and posters. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T4: T4: What research on palliative care, exercise, nutrition, survivorship do you think will impact patients lives the most - or that survivors should ask their providers about? #gyncsm
Suzie Siegel @SuzieSiegel
@btrfly12 Women with uterine #leiomyosarcoma were encouraged to get genetic testing. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @SuzieSiegel: @btrfly12 Women with uterine #leiomyosarcoma were encouraged to get genetic testing. #gyncsm
Gary L. Thompson @garyleethompson
@btrfly12 I can’t wait until all that I‘ve been working on comes to fruition. I have been cooking something, along with some special friends, for a while now. For those that know me, being quiet is not something I do well! 🤣🤣 You are all too special and too beautiful to hurt. ❤️ #gyncsm
Leigh Pate @LPseattle
Hello from Seattle #gyncsm
Dee Sparacio @womenofteal
RT @SuzieSiegel: T4 & T5. Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! #gyncsm
Bonnie Donihi @b_donihi
RT @ocrahope: Join our community partner @gyncsm for a tweet chat tonight (June 8) at 8 pm ET to discuss recent #gynecologiccancer research updates presented at this year’s #SGOmtg and #ASCO22.
GYN Cancer | #GYNCSM @gyncsm
T5: Which equity issues were presented at #SGOmtg and #ASCO22? Are we seeing progress? #gyncsm
Dee Sparacio @womenofteal
RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm
Dee Sparacio @womenofteal
@garyleethompson Your work honors her every day. #gyncsm
Christina Lizaso @btrfly12
Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm
Karen North @mzunrs
A4: COUNSELING! Diagnosis, treatment, aftercare, terminal care. It’s important for EVERYONE involved.
Suzie Siegel @SuzieSiegel
This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC
Dee Sparacio @womenofteal
@fumikochino has done great work in the area of financial toxicity. #gyncsm
Dee Sparacio @womenofteal
RT @SuzieSiegel: @btrfly12 Women with uterine #leiomyosarcoma were encouraged to get genetic testing. #gyncsm
Christina Lizaso @btrfly12
RT @SuzieSiegel: This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC
Suzie Siegel @SuzieSiegel
RT @btrfly12: Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm
Dee Sparacio @womenofteal
@LPseattle Hi Leigh, So glad you could stop by. #gyncsm
Dee Sparacio @womenofteal
RT @SuzieSiegel: This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC
Christina Lizaso @btrfly12
@SuzieSiegel Visuals are so helpful - especially when cancers are so complex. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T5: T5: Which equity issues were presented at #SGOmtg and #ASCO22? Are we seeing progress? #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @SuzieSiegel: T4 & T5. Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! #gyncsm
Dee Sparacio @womenofteal
T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker.
Suzie Siegel @SuzieSiegel
RT @womenofteal: T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker.
Dee Sparacio @womenofteal
T3 Going back to my hot topic here are 2 grpahics on Antibody drug conjugates. #gyncsm https://t.co/bvuQ4hZ3eD
Christina Lizaso @btrfly12
The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker.
Dee Sparacio @womenofteal
RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm
cathygee @cathygee
RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm
Fumiko Ladd Chino, MD @fumikochino
@womenofteal Thank you! Outside of breast cancer, #gyncsm has some of the best quality #financialtoxicity research. Including by @MLiangMD @EmelineAvikiMD and @K8SLN_MDMBA amongst others
Lisa M Guzzardi, RN @LguzzardiM
#COVID-19 Outcomes in Patients With Gynecologic Cancer ⁦@CancerTherAdvsr#gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9
Shannon Westin @ShannonWestin
RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T6: For our last topic, we'll let our participants ask any questions they have about recent gynecologic cancer research. Also, what do you want to see research resources focused on? Are there gaps in research you would like to see addressed? #gyncsm
Shannon Westin @ShannonWestin
RT @womenofteal: T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker.
GYN Cancer | #GYNCSM @gyncsm
RT @LguzzardiM: #COVID-19 Outcomes in Patients With Gynecologic Cancer ⁦@CancerTherAdvsr#gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9
Shannon Westin @ShannonWestin
RT @womenofteal: @fumikochino has done great work in the area of financial toxicity. #gyncsm
Shannon Westin @ShannonWestin
RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T6: T6: For our last topic, we'll let our participants ask any questions they have about recent gynecologic cancer research. Also, what do you want to see research resources focused on? Are there gaps in research you would like to see addressed? #gyncsm
Sarah Temkin @temkins
RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm
Suzie Siegel @SuzieSiegel
T6. I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment. #gyncsm
Dee Sparacio @womenofteal
RT @LguzzardiM: #COVID-19 Outcomes in Patients With Gynecologic Cancer ⁦@CancerTherAdvsr#gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9
Dee Sparacio @womenofteal
RT @SuzieSiegel: T6. I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment. #gyncsm
Shannon Westin @ShannonWestin
RT @DrMMurphy: T3 : T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm
Christina Lizaso @btrfly12
Any research that those on the chat are involved with? excited about? #gyncsm
Christina Lizaso @btrfly12
RT @SuzieSiegel: T6. I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment. #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
#ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK
Christina Lizaso @btrfly12
RT @LguzzardiM: #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK
Shannon Westin @ShannonWestin
RT @fumikochino: @womenofteal Thank you! Outside of breast cancer, #gyncsm has some of the best quality #financialtoxicity research. Including by @MLiangMD @EmelineAvikiMD and @K8SLN_MDMBA amongst others
Shannon Westin @ShannonWestin
RT @SuzieSiegel: This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC
Gary L. Thompson @garyleethompson
@womenofteal It was great to have a chance to meet @faceofstage4 at #ASCO22 #gyncsm
Shannon Westin @ShannonWestin
RT @btrfly12: Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm
Dee Sparacio @womenofteal
T6 I heard about women having PARP resistance - like becoming platinum resistant. I wonder how many cycles of PARP does this start? #gyncsm
Suzie Siegel @SuzieSiegel
@btrfly12 T6. https://t.co/p0wVqj4ZkB is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Thanks so much to @womenofteal @SuzieSiegel @LguzzardiM @ShannonWestin @DrMMurphy and others who share research news to #gyncsm and help keep us all informed.
Dee Sparacio @womenofteal
@garyleethompson @faceofstage4 The part I missed most was getting together with fellow advocates and sharing ideas and offering support . #gyncsm #ASCO22
GYN Cancer | #GYNCSM @gyncsm
RT @SuzieSiegel: @btrfly12 T6. https://t.co/p0wVqj4ZkB is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery. #gyncsm
Dee Sparacio @womenofteal
RT @SuzieSiegel: @btrfly12 T6. https://t.co/p0wVqj4ZkB is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery. #gyncsm
Sarah Temkin @temkins
RT @womenofteal: T3 Going back to my hot topic here are 2 grpahics on Antibody drug conjugates. #gyncsm https://t.co/bvuQ4hZ3eD
Lisa M Guzzardi, RN @LguzzardiM
New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA
Dee Sparacio @womenofteal
RT @LguzzardiM: #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK
Héphaïstos @hephaistos_ai
RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA
Suzie Siegel @SuzieSiegel
@womenofteal It may depend on the patient, but #sarcoma researchers are interested in this, too. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA
Dee Sparacio @womenofteal
RT @gyncsm: Thanks so much to @womenofteal @SuzieSiegel @LguzzardiM @ShannonWestin @DrMMurphy and others who share research news to #gyncsm and help keep us all informed.
GYN Cancer | #GYNCSM @gyncsm
Thanks for sharing, listening and learning with #gyncsm We use the last few minutes of the chat to wrap up and share what you learned or were reminded of during this chat. You can start your tweet with TIL: standing for “Today I Learned”.
Dee Sparacio @womenofteal
RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA
Gary L. Thompson @garyleethompson
@brcainfo Maureen was the “rest of me.” I will never be able to fully explain her beauty, from the inside out. I tell our stories here: https://t.co/Hq9PUtF8ej. I apologize if I’m disrupting the flow of #gyncsm @btrfly12 So much gr8 knowledge tonight.
Shannon Westin @ShannonWestin
T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm
Shannon Westin @ShannonWestin
RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA
Tobey @BRCAinfo
RT @garyleethompson: @brcainfo Maureen was the “rest of me.” I will never be able to fully explain her beauty, from the inside out. I tell our stories here: https://t.co/Hq9PUtF8ej. I apologize if I’m disrupting the flow of #gyncsm @btrfly12 So much gr8 knowledge tonight.
Tobey @BRCAinfo
RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm
Sarah Temkin @temkins
RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm
Dee Sparacio @womenofteal
@garyleethompson @faceofstage4 @jillfeldman4 and @AdrienneEcana did awesome in their presentations and representing advocates at #ASCO22. #gyncsm
Christina Lizaso @btrfly12
TIL: So appreciative of those in healthcare, including advocates, who use their platforms to share what they are studying and learning. A wonderful unpaid labor that benefits so many. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Thanks for sharing, listening and learning with #gyncsm We use the last few minutes of the chat to wrap up and share what you learned or were reminded of during this chat. You can start your tweet with TIL: standing for “Today I Learned”.
Christina Lizaso @btrfly12
RT @womenofteal: @garyleethompson @faceofstage4 @jillfeldman4 and @AdrienneEcana did awesome in their presentations and representing advocates at #ASCO22. #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: TIL: TIL: So appreciative of those in healthcare, including advocates, who use their platforms to share what they are studying and learning. A wonderful unpaid labor that benefits so many. #gyncsm
Ali Bee PhD @AliBeePhD
RT @MorganSLevy: "COVID-19 Outcomes in Patients With Gynecologic Cancer." Important abstract from @AliBeePhD at @ASCO on the impact of COVID-19 infection on #gyncsm patients. Key population to protect through vaccination and mask-wearing, and educate on COVID-19 risks! https://t.co/rsYiZYkFV9
GYN Cancer | #GYNCSM @gyncsm
Note there will be no #gyncsm chat in July 2022. Save the date for our next chat on Wednesday, August 10, 8pmET when we’ll discuss "Advocacy for yourself and others".
Tobey @BRCAinfo
RT @btrfly12: TIL: TIL: So appreciative of those in healthcare, including advocates, who use their platforms to share what they are studying and learning. A wonderful unpaid labor that benefits so many. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
As always, remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats. And visit our blog for chat recaps and other gyn cancer resources. https://t.co/oAfi7Me49e
Dee Sparacio @womenofteal
TIL That there are researchers from all over the world focused on finding better treatments for gyn cancers #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Note there will be no #gyncsm chat in July 2022. Save the date for our next chat on Wednesday, August 10, 8pmET when we’ll discuss "Advocacy for yourself and others".
Gary L. Thompson @garyleethompson
@SuzieSiegel @womenofteal @faceofstage4 @ASCO I dream of hosting a patient conference one day, where we the patients, the caregivers, the grieving, are the hosts and invite others to attend. And pay. 😀 And, I dream of a better term of than patient. ❤️ #gyncsm
Christina Lizaso @btrfly12
#gyncsm Resource | Patient Advocate @stigetta report from #SGOmtg via @ocrahope https://t.co/17EzOGSkdc
Dee Sparacio @womenofteal
Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte
Shannon Westin @ShannonWestin
Grateful for you and Christina!!! #gyncsm
Shannon Westin @ShannonWestin
RT @btrfly12: #gyncsm Resource | Patient Advocate @stigetta report from #SGOmtg via @ocrahope https://t.co/17EzOGSkdc
Christina Lizaso @btrfly12
Also @womenofteal will have #ovariancancer and other information from ASCO on her blog https://t.co/x79HJYGYsk #gyncsm
Dee Sparacio @womenofteal
Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources. #gyncsm
Christina Lizaso @btrfly12
RT @garyleethompson: @SuzieSiegel @womenofteal @faceofstage4 @ASCO I dream of hosting a patient conference one day, where we the patients, the caregivers, the grieving, are the hosts and invite others to attend. And pay. 😀 And, I dream of a better term of than patient. ❤️ #gyncsm
Dee Sparacio @womenofteal
@garyleethompson @SuzieSiegel @faceofstage4 @ASCO Hold on to that dream. I'd love to see it happen. #gyncsm
Dee Sparacio @womenofteal
Till next August Stay well Teal Sisters, healthcare providers and caregivers. #gyncsm
Sarah Temkin @temkins
RT @ShannonWestin: Grateful for you and Christina!!! #gyncsm
Shannon Westin @ShannonWestin
RT @womenofteal: Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources. #gyncsm
Shannon Westin @ShannonWestin
RT @btrfly12: Also @womenofteal will have #ovariancancer and other information from ASCO on her blog https://t.co/x79HJYGYsk #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Wishing wellness and safety for all. Thanks for being a part of #gyncsm
Tobey @BRCAinfo
@womenofteal Be well & thank you all. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Wishing wellness and safety for all. Thanks for being a part of #gyncsm
Martina Murphy, MD @DrMMurphy
@gyncsm @womenofteal @SuzieSiegel @LguzzardiM @ShannonWestin I learn so much from all of you and your lived experiences. Thankful that you are willing to share and educate! 🙏🏼 #gyncsm
Dee Sparacio @womenofteal
@DrMMurphy @gyncsm @SuzieSiegel @LguzzardiM @ShannonWestin Thanks so much for joining us tonight and for sharing info from the ASCO meeting. #gyncsm
Gary L. Thompson @garyleethompson
So glad I tuned in to #gyncsm Summer blessings to all. 🏝☀️
Shannon Westin @ShannonWestin
RT @gyncsm: Wishing wellness and safety for all. Thanks for being a part of #gyncsm
Dee Sparacio @womenofteal
@garyleethompson Glad you joined us too. #gyncsm
NCI Cancer Stats @NCICancerStats
The rate of new cases of #UterineCancer is increasing faster for Black women (2.6% per year, 1998-2019) than for White women (0.8% per year, 2002-2019). Visit SEER*Explorer to view more cancer stats: https://t.co/iRlaK2WKhS #GynCSM https://t.co/evmBeMYLrX
GYN Cancer | #GYNCSM @gyncsm
RT @NCICancerStats: The rate of new cases of #UterineCancer is increasing faster for Black women (2.6% per year, 1998-2019) than for White women (0.8% per year, 2002-2019). Visit SEER*Explorer to view more cancer stats: https://t.co/iRlaK2WKhS #GynCSM https://t.co/evmBeMYLrX
Dee Sparacio @womenofteal
#gyncsm
Dee Sparacio @womenofteal
RT @fumikochino: @womenofteal Thank you! Outside of breast cancer, #gyncsm has some of the best quality #financialtoxicity research. Including by @MLiangMD @EmelineAvikiMD and @K8SLN_MDMBA amongst others
Juan C Trabucco @Trabucco65
RT @NCICancerStats: The rate of new cases of #UterineCancer is increasing faster for Black women (2.6% per year, 1998-2019) than for White women (0.8% per year, 2002-2019). Visit SEER*Explorer to view more cancer stats: https://t.co/iRlaK2WKhS #GynCSM https://t.co/evmBeMYLrX
Georgia @_GeorgiaHurst
RT @LguzzardiM: #COVID-19 Outcomes in Patients With Gynecologic Cancer ⁦@CancerTherAdvsr#gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9
Georgia @_GeorgiaHurst
RT @LguzzardiM: #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK
GYN Cancer | #GYNCSM @gyncsm
RT @womenofteal: #gyncsm
Georgia @_GeorgiaHurst
RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors ⁦@NewsMedical#gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA
Georgia @_GeorgiaHurst
RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm
Georgia @_GeorgiaHurst
RT @btrfly12: Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm
Georgia @_GeorgiaHurst
RT @btrfly12: T2: T2: You can search for tweets with both #ASCO22 and #gyncsm to get a glimpse of some of the items covered.
Tambre Leighn, MA, PCC she/her @tambreleighn
RT @womenofteal: #gyncsm
Agus Wörner @Agus_Worner
RT @JournalCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Opportunities for precision oncology in a changing landscape https://t.co/jSpLcDxafe #gyncsm #gyncancer CC: @OncoAlert https://t.co/fxNkYeitij
Dee Sparacio @womenofteal
@fumikochino @MLiangMD @EmelineAvikiMD @K8SLN_MDMBA I followed @EmelineAvikiMD after hearing her speak on her work on packaging Lenvatinib at SGO. I will follow @MLiangMD @K8SLN_MDMBA now. #gyncsm
#GynCSM content from Twitter.